Relationship of osteopontin and renal function with severity of coronary artery lesions

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 4, 2014, Pages 1122-1127

  Chen, Jian ^a   Lu, Yingmin ^a   Huang, Damin ^a   Luo, Xiaohan ^a   Zhang, Yachen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Atherosclerosis; Coronary heart disease; Osteopontin; Renal failure

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOPONTIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY VASCULAR RESISTANCE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 84900389842     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F and Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Lorenzen J, Kramer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D and Kielstein JT. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest 2010; 40: 294-300.
3. Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N and Ohsuzu F. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003; 107: 679-681.
4. Kurata M, Okura T, Watanabe S, Fukuoka T and Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006; 111: 319-324.
5. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H and Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170: 333-337.
6. Fang X and Guan SM. Vascular remodeling of osteopontin and hypertension. Chin Heart J 2009; 19: 232-233.
7. Scatena M, Liaw L and Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
8. Yan X, Sano M, Lu L, Wang W, Zhang Q, Zhang R, Wang L, Chen Q, Fukuda K and Shen W. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2010; 9: 70.
9. Berezin AE and Kremzer AA. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis 2013; 229: 475-481.
10. Tousoulis D, Siasos G, Maniatis K, Oikonomou E, Kioufis S, Zaromitidou M, Paraskevopoulos T, Michalea S, Kollia C, Miliou A, Kokkou E, Papavassiliou AG and Stefanadis C. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. Int J Cardiol 2013; 167: 1924-1928.
11. Wang YN. Osteopontin and kidney disease. Fore Med Scie (Path and Clin Med) 2003; 23: 504-506.
12. Liu QQ. Analysis of the status of the secondary prevention of coronary heart disease. J Chin Prac Diag and Ther 2007; 21: 800-801.
13. Chonchol M, Whittle J, Desbien A, Orner MB, Petersen LA and Kressin NR. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol 2008; 28: 354-360.
14. Zhang XX, Mi SH and Han ZH. Relationship of decreased renal function and severe coronary artery disease in elderly patients with coronary heart disease. J Chin Prac Diagn Ther 2010; 24: 20-21.